To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

NCT07629583 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: Cevostamab
DRUG: Tocilizumab

Sponsor

Genentech, Inc.